The DEA relaxed online prescribing rules during covid. Now it wants to rein...
Federal regulators want most patients to see a health care provider in person before receiving prescriptions for potentially addictive medicines through telehealth — something that hasn't been required...
View ArticleBreaking the myth: opioids provide no advantage for acute back pain, study finds
The first placebo-controlled trial of opioids in acute low back and neck pain.
View ArticleOpioids linked to increased risk of death in older adults with dementia
The study population included everyone in Denmark aged 65 and older diagnosed with dementia between Jan. 1, 2008 and Dec. 31, 2018 (n=75,471), including both home-living and nursing home residents. Of...
View ArticleExperimental insomnia treatment may help prevent opioid relapse
A good night's sleep has many proven health benefits, and a new Scripps Research study suggests one more: preventing opioid relapse.
View ArticleAccelerating drug discovery with analytical R&D solutions
In this interview, Thermo Fisher Scientific discusses how to accelerate drug discovery through analytical R&D.
View ArticlePromising candidate medication for preventing and reversing fentanyl-induced...
Researchers assessed CSX-1004, a monoclonal antibody (mAb), for its efficacy in reversing fentanyl overdose based on its high affinity for fentanyl, positive animal model results, and safe...
View ArticleNew study casts doubt on effectiveness of opioids for cancer pain
The world's largest review on opioid medicines for cancer pain has found it is unclear whether some commonly used opioid medicines are better than a placebo and suggests that non-opioid medicines,...
View ArticleNew study challenges "gold standard" opioid treatment for cancer pain
Researchers examining the data on opioids for pain caused by cancer have found surprisingly large gaps in evidence regarding the true benefits of these medicines for cancer pain.
View ArticleUsing AI to break the opioid addiction cycle
When Ben Brown, research assistant professor of chemistry, thinks about the opioid epidemic, he views the problem on a molecular level.
View ArticleRecords show Publix opioid sales grew even as addiction crisis prompted other...
An executive at Teva Pharmaceuticals flagged Publix Super Markets in October 2015 after detecting what he called in an email "serious red flags" with the grocery chain's orders of powerful opioids.
View ArticleDNA aptamer-based sensors can accurately detect trace amounts of fentanyl,...
Researchers from North Carolina State University have developed a new generation of high-performance DNA aptamers and highly accurate drug sensors for cocaine and other opioids.
View ArticleA paramedic was skeptical about this Rx for stopping repeat opioid overdoses....
Fire Capt. Jesse Blaire steered his SUV through the mobile home park until he spotted the little beige house with white trim and radioed to let dispatchers know he'd arrived.
View Article
